← Eichor
Condition: Focal Drug Resistant Epilepsy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Focal Drug Resistant Epilepsy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Atlas of Human Cognition by SEEG (MAPCOG-SEEG)
Phase N/A · 4 location(s) · University Hospital, Grenoble · NCT03644732Exploring the Characteristics of Epileptogenic Foci in Drug-Resistant Epilepsy Based on Multimodal Imaging Technology
Phase N/A · 1 location(s) · Xijing Hospital · NCT06557720Multimodal Study of the Human Brain Epilepsy Tissue
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06022055Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables
NA · 1 location(s) · Mayo Clinic · NCT07012148Study for the Diagnosis and Treatment of Drug-resistant Focal Epilepsies
Phase N/A · 1 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06794606Spatial Scene Recognition Memory in Epilepsy Surgery
NA · 2 location(s) · University of California, Davis · NCT07580183A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Dr
Phase 1/Phase 2 · 3 location(s) · NaviFUS Corporation · NCT06388707Impact of Epileptic Discharge on the Structural Connectivity of the Developing Brain
Phase N/A · 1 location(s) · Fondation Ophtalmologique Adolphe de Rothschild · NCT03268824Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell T
Phase 3 · 35 location(s) · Neurona Therapeutics · NCT05135091A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Phase 2/Phase 3 · 124 location(s) · Biohaven Therapeutics Ltd. · NCT06132893Low Intensity Focused Ultrasound Epilepsy: A Pilot Trial
NA · 1 location(s) · Brigham and Women's Hospital · NCT03868293Cognitive Impairment in Drug-resistant and Drug-responsive Focal Cryptogenic Epilepsy
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06210022The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy
EARLY_Phase 1 · 1 location(s) · Xuanwu Hospital, Beijing · NCT07095933Electroclinical Correlation of Anxiety
NA · 1 location(s) · University Hospital, Bordeaux · NCT05393518Biomarkers of Response to SEEG Thermocoagulation
NA · 1 location(s) · Assistance Publique Hopitaux De Marseille · NCT07399327Subthalamic Nucleus Electrical Stimulation for Drug-resistant Focal Motor Epilepsy
NA · 1 location(s) · Xuanwu Hospital, Beijing · NCT06248333Evaluation of the NaviFUS System in Drug Resistant Epilepsy
NA · 1 location(s) · Genovate-NaviFUS (Australia) Pty Ltd. · NCT05947656National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852Localizing Epileptic Networks Using MRI and iEEG
EARLY_Phase 1 · 1 location(s) · University of Pennsylvania · NCT04649008Focused Ultrasound for Drug-resistant Epilepsy
NA · 1 location(s) · Taipei Veterans General Hospital, Taiwan · NCT06292494Sirolomus Adjuvant Treatment of Focal Refractory Epilepsy (SATFRE)
EARLY_Phase 1 · 1 location(s) · Xuanwu Hospital, Beijing · NCT06719791A PET-MRI Study of Serotoninergic Brainstem Pathway in Patients With Dravet Syndrome
NA · 1 location(s) · Hospices Civils de Lyon · NCT07013331Links Between Epileptic Activity, Sleep Disruption and Mental Content During Sleep
Phase N/A · 2 location(s) · Hospices Civils de Lyon · NCT07605858Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy
NA · 1 location(s) · University of California, San Francisco · NCT07680842Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy
Phase 2 · 10 location(s) · Supernus Pharmaceuticals, Inc. · NCT05518578A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Re
NA · 1 location(s) · NaviFUS Corporation · NCT06492720Genetic and Electrophysiologic Study in Focal Drug-resistant Epilepsies
Phase N/A · 1 location(s) · Fondation Ophtalmologique Adolphe de Rothschild · NCT02890641Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy
Phase 1 · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT02531880
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.